Copyright Reports & Markets. All rights reserved.

Global Argatroban Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Argatroban Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Argatroban Market Size Growth Rate by Type
    • 1.4.2 Argatroban Powder
    • 1.4.3 Argatroban Injection
  • 1.3 Market by Application
    • 1.3.1 Global Argatroban Market Size Growth Rate by Application
    • 1.3.2 Heparin-induced Thrombocytopenia (HIT)
    • 1.3.3 Percutaneous Coronary Intervention
    • 1.3.4 Cerebral Arterial Thrombosis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Argatroban Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Argatroban Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Argatroban Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Argatroban Regions by Sales
    • 2.4.1 Global Top Argatroban Regions by Sales (2016-2021)
    • 2.4.2 Global Top Argatroban Regions by Sales (2022-2027)
  • 2.5 Global Top Argatroban Regions by Revenue
    • 2.5.1 Global Top Argatroban Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Argatroban Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Argatroban Sales by Manufacturers
    • 3.1.1 Global Top Argatroban Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Argatroban Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Argatroban Sales in 2020
  • 3.2 Global Argatroban Revenue by Manufacturers
    • 3.2.1 Global Top Argatroban Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Argatroban Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Argatroban Revenue in 2020
  • 3.3 Global Argatroban Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Argatroban Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Argatroban Sales by Type
    • 4.1.1 Global Argatroban Historical Sales by Type (2016-2021)
    • 4.1.2 Global Argatroban Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Argatroban Sales Market Share by Type (2016-2027)
  • 4.2 Global Argatroban Revenue by Type
    • 4.2.1 Global Argatroban Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Argatroban Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Argatroban Revenue Market Share by Type (2016-2027)
  • 4.3 Global Argatroban Price by Type
    • 4.3.1 Global Argatroban Price by Type (2016-2021)
    • 4.3.2 Global Argatroban Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Argatroban Sales by Application
    • 5.1.1 Global Argatroban Historical Sales by Application (2016-2021)
    • 5.1.2 Global Argatroban Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Argatroban Sales Market Share by Application (2016-2027)
  • 5.2 Global Argatroban Revenue by Application
    • 5.2.1 Global Argatroban Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Argatroban Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Argatroban Revenue Market Share by Application (2016-2027)
  • 5.3 Global Argatroban Price by Application
    • 5.3.1 Global Argatroban Price by Application (2016-2021)
    • 5.3.2 Global Argatroban Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Argatroban Market Size by Type
    • 6.1.1 North America Argatroban Sales by Type (2016-2027)
    • 6.1.2 North America Argatroban Revenue by Type (2016-2027)
  • 6.2 North America Argatroban Market Size by Application
    • 6.2.1 North America Argatroban Sales by Application (2016-2027)
    • 6.2.2 North America Argatroban Revenue by Application (2016-2027)
  • 6.3 North America Argatroban Market Size by Country
    • 6.3.1 North America Argatroban Sales by Country (2016-2027)
    • 6.3.2 North America Argatroban Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Argatroban Market Size by Type
    • 7.1.1 Europe Argatroban Sales by Type (2017-2027)
    • 7.1.2 Europe Argatroban Revenue by Type (2017-2027)
  • 7.2 Europe Argatroban Market Size by Application
    • 7.2.1 Europe Argatroban Sales by Application (2017-2027)
    • 7.2.2 Europe Argatroban Revenue by Application (2017-2027)
  • 7.3 Europe Argatroban Market Size by Country
    • 7.3.1 Europe Argatroban Sales by Country (2017-2027)
    • 7.3.2 Europe Argatroban Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Argatroban Market Size by Type
    • 8.1.1 Asia Pacific Argatroban Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Argatroban Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Argatroban Market Size by Application
    • 8.2.1 Asia Pacific Argatroban Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Argatroban Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Argatroban Market Size by Region
    • 8.3.1 Asia Pacific Argatroban Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Argatroban Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Argatroban Market Size by Type
    • 9.1.1 Latin America Argatroban Sales by Type (2019-2027)
    • 9.1.2 Latin America Argatroban Revenue by Type (2019-2027)
  • 9.2 Latin America Argatroban Market Size by Application
    • 9.2.1 Latin America Argatroban Sales by Application (2019-2027)
    • 9.2.2 Latin America Argatroban Revenue by Application (2019-2027)
  • 9.3 Latin America Argatroban Market Size by Country
    • 9.3.1 Latin America Argatroban Sales by Country (2019-2027)
    • 9.3.2 Latin America Argatroban Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Argatroban Market Size by Type
    • 6.1.1 Middle East and Africa Argatroban Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Argatroban Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Argatroban Market Size by Application
    • 6.2.1 Middle East and Africa Argatroban Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Argatroban Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Argatroban Market Size by Country
    • 6.3.1 Middle East and Africa Argatroban Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Argatroban Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Pfizer, Inc
    • 11.1.1 Pfizer, Inc Corporation Information
    • 11.1.2 Pfizer, Inc Overview
    • 11.1.3 Pfizer, Inc Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Pfizer, Inc Argatroban Product Description
    • 11.1.5 Pfizer, Inc Related Developments
  • 11.2 SANDOZ
    • 11.2.1 SANDOZ Corporation Information
    • 11.2.2 SANDOZ Overview
    • 11.2.3 SANDOZ Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 SANDOZ Argatroban Product Description
    • 11.2.5 SANDOZ Related Developments
  • 11.3 GlaxoSmithKline Plc
    • 11.3.1 GlaxoSmithKline Plc Corporation Information
    • 11.3.2 GlaxoSmithKline Plc Overview
    • 11.3.3 GlaxoSmithKline Plc Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 GlaxoSmithKline Plc Argatroban Product Description
    • 11.3.5 GlaxoSmithKline Plc Related Developments
  • 11.4 fresenius-kabi
    • 11.4.1 fresenius-kabi Corporation Information
    • 11.4.2 fresenius-kabi Overview
    • 11.4.3 fresenius-kabi Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 fresenius-kabi Argatroban Product Description
    • 11.4.5 fresenius-kabi Related Developments
  • 11.5 Eagle Pharmaceuticals, Inc
    • 11.5.1 Eagle Pharmaceuticals, Inc Corporation Information
    • 11.5.2 Eagle Pharmaceuticals, Inc Overview
    • 11.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Eagle Pharmaceuticals, Inc Argatroban Product Description
    • 11.5.5 Eagle Pharmaceuticals, Inc Related Developments
  • 11.6 Mitsubishi Tanabe Pharma
    • 11.6.1 Mitsubishi Tanabe Pharma Corporation Information
    • 11.6.2 Mitsubishi Tanabe Pharma Overview
    • 11.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Mitsubishi Tanabe Pharma Argatroban Product Description
    • 11.6.5 Mitsubishi Tanabe Pharma Related Developments
  • 11.7 Teva Pharmaceutical Industries Ltd
    • 11.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
    • 11.7.2 Teva Pharmaceutical Industries Ltd Overview
    • 11.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Teva Pharmaceutical Industries Ltd Argatroban Product Description
    • 11.7.5 Teva Pharmaceutical Industries Ltd Related Developments
  • 11.8 WEST-WARD,INC
    • 11.8.1 WEST-WARD,INC Corporation Information
    • 11.8.2 WEST-WARD,INC Overview
    • 11.8.3 WEST-WARD,INC Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 WEST-WARD,INC Argatroban Product Description
    • 11.8.5 WEST-WARD,INC Related Developments
  • 11.1 Pfizer, Inc
    • 11.1.1 Pfizer, Inc Corporation Information
    • 11.1.2 Pfizer, Inc Overview
    • 11.1.3 Pfizer, Inc Argatroban Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Pfizer, Inc Argatroban Product Description
    • 11.1.5 Pfizer, Inc Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Argatroban Value Chain Analysis
  • 12.2 Argatroban Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Argatroban Production Mode & Process
  • 12.4 Argatroban Sales and Marketing
    • 12.4.1 Argatroban Sales Channels
    • 12.4.2 Argatroban Distributors
  • 12.5 Argatroban Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Argatroban Industry Trends
  • 13.2 Argatroban Market Drivers
  • 13.3 Argatroban Market Challenges
  • 13.4 Argatroban Market Restraints

14 Key Findings in The Global Argatroban Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Argatroban market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Argatroban market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Argatroban Powder
    Argatroban Injection

    Segment by Application
    Heparin-induced Thrombocytopenia (HIT)
    Percutaneous Coronary Intervention
    Cerebral Arterial Thrombosis

    By Company
    Pfizer, Inc
    SANDOZ
    GlaxoSmithKline Plc
    fresenius-kabi
    Eagle Pharmaceuticals, Inc
    Mitsubishi Tanabe Pharma
    Teva Pharmaceutical Industries Ltd
    WEST-WARD,INC

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now